The measurement of ApoB and ApoA1 does not require fasting samples and is standardized, making the ApoB/ApoA1 ratio a more balanced, comprehensive, and stable indicator of lipid metabolism and a predictor of cardiovascular disease and diabetes (Jing et al., 2014; Nurtazina et al., 2020). This evidence concerns the gene APOB and cardiovascular disorder.